Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Major US indexes gyrate, now mixed: Nasdaq, S&P gain, Dow slips* Utilities lead S&P sector gainers; materials weakest group* Euro STOXX 600 edges higher* Dollar, gold rise; crude dips* US 10-Year Treasury yield ~1.11%Jan 13 - Welcome to the home f...
Read more* Major U.S. stock indexes churn near flat line, Nasdaq up front* Utilities leads gainers among S&P sectors; materials lag* Euro STOXX 600 edges higher* Dollar, gold, crude advance* US 10-Year Treasury yield ~1.10%Jan 13 - Welcome to the home for re...
Read more
Glaxo, Pfizer's ViiV Gets EU Approval For Tivicay In Children With HIV
Read more(adds details and context)BRUSSELS, Jan 12 (Reuters) - The European Union said on Tuesday it had concluded exploratory talks with the French drugmaker Valneva for the supply of up to 60 million doses of its COVID-19 vaccine candidate.Valneva is th...
Read moreVectura Forecasts 2020 Earnings To Top Board Expectations
Read moreTOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed Trial
Read moreBRUSSELS, Jan 8 (Reuters) - EU countries are not allowed to negotiate separate vaccine deals with pharmaceutical companies in parallel to the efforts of the European Union as a whole, the president of the European Commission Ursula von der Leyen s...
Read more(Adds detail, quotes)BRUSSELS, Jan 8 (Reuters) - The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, doubling the amount of doses from these producers, the head of the European Co...
Read moreBRUSSELS, Jan 8 (Reuters) - The head of the European Commission Ursula von der Leyen said on Friday the EU had reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccines, doubling the amount of doses fro...
Read moreUK DIRECTOR DEALINGS SUMMARY: Rio Tinto Copper & Diamonds Chief Sells
Read moreVectura Says Glaxo Will Not Appeal Award In Ellipta Litigation
Read more
(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Brexit deal sparks rally in UK stocks* FTSE 100 at highest since March* Hut Group rises on online retailer acquisition* FTSE 100 up 1.6%, F...
Read more(adds Pfizer reply)By Francesco GuarascioBRUSSELS, Dec 28 (Reuters) - The distribution of an initial 200 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech across the European Union will be completed by September, a spokesman f...
Read more
Last checked at